DISTRIBUTION AND COMMERCIALIZATION AGREEMENTDistribution and Commercialization Agreement • November 7th, 2014 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DISTRIBUTION AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is entered into as of July 18, 2014 (the “Effective Date”) by and between ANACOR PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 1020 East Meadow Circle, Palo Alto, CA 94303 (“Anacor”) and SANDOZ INC., a Colorado corporation having its principal place of business at 506 Carnegie Center, Suite 400, Princeton, NJ 08540 (“Sandoz”). Anacor and Sandoz are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
MANUFACTURING AGREEMENTManufacturing Agreement • November 7th, 2014 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT is made and entered into effective as of the 30th day of September, 2014, by and between Anacor Pharmaceuticals, Inc, a company with its principal place of business at 1020 East Meadow Circle, Palo Alto, California 94303-4230, USA (“COMPANY”), and Hovione FarmaCiencia SA, a company with its principal place of business at Sete Casas, 2674-506 Loures, Portugal (“HOVIONE”).
